MARCO:POLO Marginalization & COVID-19: Promoting Opportunities for Learning & Outreach

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 202109EG3

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $247,905.16
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    Unity Health Toronto
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Policy research and interventions

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Many Toronto organizations rapidly introduced programs and innovations to support people experiencing marginalization during the COVID-19 pandemic. The MARCO (Marginalization and COVID-19) study, a collaboration between academic and community investigators, is using program evaluation methods to evaluate such community-led interventions. Our focus in MARCO was on using descriptive and deductive analyses to identify findings with the greatest potential for immediate impact, with a focus on service delivery that is more equitable and client-centered. However, the large amount of data that we collected offers additional opportunities. MARCO:POLO is an extension study to MARCO; our aim is to generate a deeper understanding of marginalization in health by addressing questions across evaluations, with a specific focus on systems and policy-oriented frameworks and questions addressing innovation and racism. Our approach is based on the understanding that this level of analyses is necessary for driving social change.